DOCSLIB.ORG

Legal-Graphics' 6-26-21 COVID Timeline

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No. 3 Pfizer vaccine Japan has found Initial Israeli data: Vaccine skepticism shows its vaccine 1st rapid virus test 12 million ... spread economy is Christmas trees emergency states with the huge vaccination number of deaths OK’d in days - and Moderna US nursing homes and Moderna the world prevent COVID-19 which countries were developed by county showing for England, at least appears effective a new Covid variant First Pfizer shot hurts East European Signs of Virus is more than that gives results 'faster' and 'broader' worrisome skyrockets amid authorization their highest number plan watched by country (by “normal” next fall vaccines work? vaccines compare infection have rolled out so quickly risk for COVID six weeks at home against mutation in curbs infections by anti-virus efforts at home as virus toll of virus number of days a COVID-19 vaccine new virus variants 50% after 14 days 94% effective than ever coronavirus vaccine of virus deaths by the world in those exposed? Jan. 11, 2021 Key Events inflicts damage since 100 deaths Dec. 18, 2020 Dec. 22, 2020 Dec. 31, 2020 Jan. 6, 2021 Jan. 17, 2021 Dec. 12, 2020 Dec. 15, 2020 Dec. 21, 2020 Jan. 4, 2021 US vaccine rollout US virus deaths Vaccines across Dec. 30, 2020 Jan. 9, 2021 Jan. 14, 2021 Dec. 1, 2020 Dec. 4, 2020 Dec. 7, 2020 Dec. 27, 2020 Where the world problematic Elderly hunger is Good News! Nov. 17, 2020 Nov. 19, 2020 Nov. 23, 2020 Nov. 28, 2020 Experts to consider and cases set Variant of virus 82 year old EU agency approves Dec. 9, 2020 Tracking nine of the US Nov. 26, 2020 The European Union records spreading across December is the Britain becomes 1st stands on dialysis patient Moderna vaccine US vaccine rollout STUDY: Recovering on the rise Governors ratchet > 900 Mayo Clinic AstraZeneca vaccine United Airlines Job growth China prepares the most promising approving Moderna Legal Matters eyes Dec 29, 2020 UK sending it deadliest month country to approve vaccination rollout gets first hits a snag from Covid gives during Covid up restrictions staff diagnosed (which only needs Macy’s is flying Pfizer slows sharply large-scale rollout US Hospitals under COVID-19 vaccines vaccine for US Jan. 11, 2021 approval for into “Tier Four” Dec. 23, 2020 in the US since the AstraZeneca vaccine AstraZeneca jab similar level of ahead of with COVID-19 to be refrigerated Thanksgiving Day COVID-19 vaccine as pandemic takes of coronavirus “extreme stress” Jan. 6, 2021 Dec. 19, 2020 lockdown coronavirus In US, Oklahoma’s protection to vaccine Oklahoma Events Thanksgiving - not frozen, like Parade marches on! 1st virus vaccine toll on economy vaccines and “overloaded” Jan. 1, 2021 Jan. 9, 2021 Jan. 18, 2021 Thailand grapples pandemic began Vaccine refusers scheduling portal Pfizer and Moderna) Dec. 13, 2020 Dec. 16, 2020 How many COVID-19 Dec. 30, 2020 Jan. 4, 2021 with virus outbreak may be limited Queen launches Israel trades Pfizer Economic News found to be 70-90% vaccines has each Demand for Jan. 15, 2021 Nov. 29, 2020 Dec. 2, 2020 Dec. 5, 2020 Canada secures Dec. 21, 2020 1st US case of virus Britain's jab blitz doses for effective Nov. 26, 2020 Dec. 10, 2020 Historic U.S. COVID country bought? rescue animals US vaccine Jan. 12, 2021 vaccine campaign early doses from Dec. 27, 2020 variant detected has skyrocketed administation Tracking US medical data Pandemic The 5 US states Moscow opens US Congress Dec. 23, 2020 Jan. 7, 2021 Hospitalizations launches with Moderna in Colorado tracker Irish infection rate COVID vaccine calls off Christmas with the most dozens of Sweden pulls a seals agreement “Hug booth” allows Jan. 10, 2021 in the US convoy of trucks US reports highest “world’s highest” distribution by state markets in Europe hospitalizations coronavirus U-turn and proposes on $900 billion US buys more doses nursing home hit another record Jan. 2, 2021 single-day death toll vaccination centers a lockdown law COVID relief bill of Pfizer vaccine residents to touch Johnson under fire as UK again faces Dec. 2, 2020 Dec. 13, 2020 their loved ones Jan. 12, 2021 Israel leads vaccine onslaught of Jan. 16, 2021 race with 12% Dec. 24, 2020 COVID-19 US reports its COVID-19 vaccine given jab Potential super China has suffered highest one-day in Oklahoma: spreader event a surge of cases death tally: Who gets it first? Santa Claus since December Overview: Over 2,800 is “good to go!” Year 1 of COVID Jan.Jan. 22,7, 2021 2021 Jan.Jan. 29,7, 2021 2021 Feb. 5, 2021 Feb. 13, 2021 Feb. 24, 2021 Mar. 7, 2021 Mar. 18, 2021 Mar. 29, 2021 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,900,0002,100,000 over 1,900,0002,200,000 over 2,300,000 over 2,400,000 over 2,500,000 over 2,600,000 over 2,700,000 over 2,800,000 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 Jan. 19, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 7, 2021 Feb. 10, 2021 Feb. 13, 2021 Feb. 16, 2021 Feb. 17,19, 2021 Feb. 17,22, 2021 Feb. 17,25, 2021 Feb. 17,27, 2021 Feb.Mar. 17,2, 2021 2021 Feb.Mar. 17,5, 2021 2021 Feb.Mar. 17,8, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb.Mar. 22,17, 2021 Feb.Mar. 25,17, 2021 Feb.Mar. 28,17, 2021 A new COVID-19 Lucky few hit Bernie happy his How is the COVID-19 US hospitalizations Israel's vaccine Johnson &Johnson Richer countries The US needs more Should you mix and India’s dramatic fall How the US states US death toll Comparing the Diagram of the Chinese vaccines Countries making FDA issues EUA Israel’s cases drop AstraZeneca’s EU Flashcards for Uptick of infections AstraZeneca vaccine Scientists mull clues “VIPIT” syndrome challenge: Mutations vaccine jackpot memes may raise vaccination campaign and ICU numbers rollout linked to seeks vaccine stockpile vaccines; viral sequencing match COVID-19 of cases leaves rank for safety nears 500,000 Spanish Flu to many mutations sweep much of dubious claims over for T-cell test after lockdown exit vaccine woes the main vaccines in 15 US states safe and effective on virus’ origin associated with rise along with cases for rare extra doses money for charity going in your state? are dropping infection fall clearance with FDA Africa is being How is your vaccines? experts stumped during COVID the COVID pandemic the world Covid-19 cases in new trial data AztraZeneca vaccine left behind state doing? Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb. 17,22, 2021 Feb. 17,28, 2021 Feb.Mar. 17,9, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 26,17, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 14, 2021 Feb.Mar. 23,17, 2021 Jan. 20, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Feb. 16, 2021 Feb. 17,20, 2021 Feb. 17,25, 2021 Feb.Mar. 17,3, 2021 2021 Feb.Mar. 17,5, 2021 2021 Signs the pandemic Feb.Mar. 29,17, 2021 Feb. 7, 2021 South African UK Study: Novavax UK variant detected Thai PM gets Two emerging Feb.
Recommended publications
  • 0 January to July 2021

    0 January to July 2021

    0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................
  • 23 April 2020 Update

    23 April 2020 Update

    20 April – 23 April 2020 Contents I. Summary .............................................................................................................................1 II. European Union .................................................................................................................5 III. France ...............................................................................................................................6 IV. Italy ...................................................................................................................................7 V. Germany ............................................................................................................................8 VI. Spain ...............................................................................................................................10 VII. United Kingdom .............................................................................................................10 I. SUMMARY Number of cases: 1,009,762 (including the UK) Number of deaths: 108,223 • The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a meeting on 15 April to discuss the progress of the measures regarding availability of medicines for European patients during the COVID-19 pandemic. They also updated the Q&A document on regulatory expectations for medicinal products for human use during the COVID-19 pandemic on 20 April. On 21 April, they set-up the fast-track system to support essential medicines for COVID-19 treatment,
  • COVID-19 Summary of Guidelines

    COVID-19 Summary of Guidelines

    [3] Table of Contents 1. Containment Plan for Large Outbreaks: Novel Corona Virus Disease 2019 (COVID-19 ............................... 7 2. Social Stigma Associated with COVID-19....................................................................................................... 7 3. Guidelines for Dialysis with reference to COVID 19 Infection ....................................................................... 7 4. Guidance document on appropriate management of suspect/ confirmed cases of COVID 19......................... 7 5. COVID - 19 testing laboratories approved and supported by ICMR as on 07/04/2020 ................................... 8 6. Railways meet half initial target in a quick time ............................................................................................... 8 7. DST supported healthcare startup developing rapid test for detection of COVID-19 .................................... 8 8. Check urgently the virus of misinformation on COVID-19: Vice President .................................................... 8 9. Guidelines for Quarantine facilities................................................................................................................. 9 10. Advisory on use of Homemade Protective Cover for Face & Mouth .............................................................. 9 11. Advisory to start rapid antibody-based blood test for COVID-19 .................................................................. 9 12. MHA writes to States/UTs to ensure smooth Disbursal of Money to beneficiaries
  • Ifs Recommendations for Covid 19 Vaccination Before Art

    Ifs Recommendations for Covid 19 Vaccination Before Art

    16 – 17 JULY 2020 PRAGATI MAIDAN - DELHI INDIAN FERTILITY SOCIETY IFS RECOMMENDATIONS FOR COVID 19 VACCINATION BEFORE ART IFS SECRETARIAT +91 11 40018184 +91 9899308083 indianferlitysociety [email protected] www.indianferlitysociety.org indianferlitysociety 302, 3rd Floor, Kailash Building, ifsdelhi 26, Kasturba Gandhi Marg, C.P. New Delhi - 110001 Cosmo Tech is the Most Important Trade show for the Suppliers to EXPAND Strengthen Increase Multiply Profits New Markets Pan New Market Customer Base India & World Customer Soaring Boost Network Brand Sales Brand Recall Value with the Industry Visibility ORGANIZED BY CALL EMAIL +91 9971811937 [email protected] +91 9999302797 [email protected] +91 9811141938 [email protected] W W W .C O SMO TEC HEXPO IND IA .C O M Dr. Sudha Prasad Dr. Neena Malhotra President Secretary General Indian Fertility Society Indian Fertility Society Director, Matritava Advanced IVF & Professor, ART Centre, Department of Training Cenre, Vasant Vihar, New Delhi Obstetrics and Gynaecology, AIIMS, New Delhi Dr. Sonia Malik Dr. Kuldeep Jain Past President Indian Fertility Society, Past President Indian Fertility Society, Director & Nova Southend Fertility & Director, KJIVF New Delhi IVF Delhi NCR Dr. KU Kunjumoideen Dr. A K Pandey Joint Secretary Indian Fertility Society, Dean Academics &. Co Ordinator Director ARMC IVF Calicut. Molecular Lab. ESI Medical college Faridabad Dr. Charu Jandial Dr. Sumita Aggarwal Member IFS, Consultant, Member IFS, Fellow, Nova Southend Fertility & IVF Delhi NCR Nova Southend Fertility & IVF Delhi NCR Introduction The coronavirus pandemic has wreaked havoc on life In these trying mes, as sociees are gradually trying to and healthcare globally. According to WHO database as return to a state of normalcy, it is also important to on 7th June 2021, there have been 173 million consider sexual and reproducve health of people.
  • Written Evidence from Spotlight on Corruption1 (PGG18) the Public

    Written Evidence from Spotlight on Corruption1 (PGG18) the Public

    Written evidence from Spotlight on Corruption1 (PGG18) The Public Administration and Constitutional Affairs Committee Propriety of governance in light of Greensill inquiry Introduction The revelations arising from the Greensill affair and its fallout, coming alongside other recent and ongoing scandals, have exposed significant weaknesses in the UK system for managing conflicts of interest, lobbying, and business appointments. This is a vital opportunity to bring the UK’s standards landscape up to date, and to ensure that integrity and ethics in government are regulated in a way that befits a modern democracy. Taking action to strengthen the UK’s integrity and ethics framework would benefit the UK by helping to: build trust in politicians and government; strengthen the stability, predictability and attractiveness of the UK as a place to do business; give the UK greater credibility on the international stage in promoting democracy and good governance; and implement outstanding recommendations made by international bodies such as the UN and Council of Europe about how the UK can improve its integrity and ethics framework to prevent and tackle corruption. Key Recommendations 1. Integrity and Ethics legislation. The government should consult on the introduction of an Integrity and Ethics Bill, by the spring of 2022, which gives legislative effect to: the Law Commission’s recommendations on the introduction of a corruption in public office offence; recommendations made by international bodies to put ACOBA and the Independent Advisor on Ministerial Interests on a statutory footing; recommendations that are likely to be made by the Committee on Standards in Public Life’s Standards Matters 2.0 review in the Autumn of 2021; and recommendations likely to be made from both the Boardman review and parliamentary committees such as PACAC, including legislative reform to the Lobbying Act.
  • Bcpct]Ttsbc^Prc U^A Dq[XRV^^S

    Bcpct]Ttsbc^Prc U^A Dq[XRV^^S

    6 < %()(=#%% 53%7==,>3='$()6(=#%% (#-'>3='$()6(=#%% $'()"*$+&,- %( !"# $$%& 2(*3-% (566)(37)% 3 0 4 $5 3 $1 2 0 .8 9 8 ++0 0 .:; . !" . / 01 $ %'( $) '# *' it for the last eight to nine notable achievements to its months, “where is the UN in name in the 75 years of its aking a strong case for a this joint fight. Where is the experience, including the pre- Msignificant role for India effective response.” vention of a third world war, in the United Nations, Prime Focussing on a more “we can’t deny terrorist attacks 0 Minister Narendra Modi on prominent role for India in the shook the world”. Saturday stressed the need for UN and fight against corona, “We have successfully ne of the oldest partners changes in the international the Prime Minister avoided avoided a third world war but Oof the BJP — the body and questioned its posi- making any reference to ongo- we cannot deny many wars Shiromani Akali Dal — which tion in fighting the coron- ing tension at the Line of happened, many civil wars has been with it through thick avirus pandemic. Actual Control (LAC) and happened. Terrorist attack and thin for decades, finally He also assured the global frosty ties with Pakistan in his shook the world. Blood was quit the National Democratic Q community that India will pro- 20-minute speech. He also did spilled. Those were killed were Alliance (NDA) on Saturday, vide corona vaccine to the not respond to Pakistan Prime like you and me. Children left signaling a complete political world as it is the world’s biggest Minister Imran Khan’s remarks the world prematurely,” he said.
  • Summary of National Advisory Committee on Immunization (Naci) Updates of July 2, 2021

    Summary of National Advisory Committee on Immunization (Naci) Updates of July 2, 2021

    SUMMARY OF NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (NACI) UPDATES OF JULY 2, 2021 MRNA COVID-19 VACCINES AND MYOCARDITIS On July 2, 2021, the Public Health Agency of Canada released updated advice from the National Advisory Committee on Immunization (NACI) on the use of mRNA COVID-19 vaccines. These recommendations are based on current scientific evidence and NACI's expert opinion. On June 30, 2021, Health Canada updated the product monographs, the documents that provide information for health care providers on the use of the vaccines, for the mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) to include very rare reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination. In light of these changes, NACI is providing updated advice on second doses for individuals who experienced myocarditis and/or pericarditis after receiving a first dose of an mRNA vaccine. NACI continues to strongly recommend that a complete series with an mRNA vaccine should be offered to all eligible individuals without contraindications, including those 12 years of age and older. The Pfizer-BioNTech vaccine is approved for use in people 12 years and over and the Moderna vaccine is approved for use in people 18 years of age and over. NACI is now also recommending the following: Informed consent for people receiving an mRNA vaccine should include a discussion about the very rare risk of myocarditis and/or pericarditis following immunization. As a precaution, NACI recommends that individuals who experienced myocarditis and/or pericarditis after a first dose of an mRNA vaccine should wait to get their second dose until more information is available.
  • HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No

    HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No

    Follow us on: @TheDailyPioneer facebook.com/dailypioneer HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No. TELENG/2018/76469 Established 1864 Published From HYDERABAD DELHI LUCKNOW BHOPAL RAIPUR CHANDIGARH BHUBANESWAR RANCHI DEHRADUN VIJAYAWADA *LATE CITY VOL. 3 ISSUE 226 *Air Surcharge Extra if Applicable www.dailypioneer.com Managed second wave, P RBI keeps interest rates unchanged P ‘Keen on signing scripts P ‘very well’; ready for 3rd: NITIA that are fun 5 announces measures to aid economy 8 entertaining, challenging’ 11 In brief IMPORT VACCINE, SAVE Petrol crosses Etela quits Assembly, TRS Pfizer vaccine for Rs 100/litre Ex-minister confirms he would be joining BJP; 12-15 age group PEOPLE, KTR TELLS CENTRE mark in TS, AP launches no-holds-barred attack on KCR gets nod in the UK ML MELLY MAITREYI ritain's medicines regulator said PNS n HYDERABAD PNS n NEW DELHI n HYDERABAD Friday the Pfizer/BioNTech B vaccine is safe for adolescents Minister KT Rama Rao on Friday After Rajasthan, Madhya Pradesh Former minister Etela Rajender let aged 12 to 15 after a "rigorous review", targeted the Centre again for its and Maharashtra, petrol price the suspense over his political following similar assessments in the “bungling” on Covid-19 vaccina- has crossed the Rs 100-per-litre future hang for some time even as EU and US."We have carefully tion and demanded that it imme- mark in almost all districts of AP he resigned from the Membership reviewed clinical trial data in children diately import vaccines from coun- and parts of Telangana after fuel of the State Legislative Assembly aged 12 to 15 years and have tries that are sitting on a huge prices were again hiked on Friday.
  • UK COVID-19 Vaccines Delivery Plan

    UK COVID-19 Vaccines Delivery Plan

    UK COVID-19 vaccines delivery plan Published 11 January 2021 Contents 1. Ministerial foreword ....................................................................................................... 3 2. Executive summary and scope ..................................................................................... 4 Supply .............................................................................................................................. 5 Prioritisation ...................................................................................................................... 6 Places ............................................................................................................................... 7 People .............................................................................................................................. 8 Tracking our progress ....................................................................................................... 9 3. Supply ......................................................................................................................... 10 Developing new vaccines ............................................................................................... 10 Ensuring vaccines meet strict safety standards for deployment ..................................... 17 Building UK manufacturing capability ............................................................................. 21 4. Prioritisation ...............................................................................................................
  • Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles.
  • SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized leader in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. In addition, Dr. Madad is Core Faculty in the National Ebola Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR) and Assistant Professor in the Graduate Biotechnology/Biodefense Program at the University of Maryland. She is an Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program. Dr. Madad earned her Doctoral degree in Health Science with a concentration in Global Health from Nova Southeastern University, graduating with Alpha Eta Health Science Honor Society status. She obtained her Master of Science degree in Biotechnology with a concentration in Biodefense and Biosecurity and Bachelor of Science degree in Psychology from the University of Maryland. Dr. Madad holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training.
  • COVID-19 Interim Vaccination Plan V.5 Pennsylvania

    COVID-19 Interim Vaccination Plan V.5 Pennsylvania

    COVID-19 Interim Vaccination Plan V.5 Pennsylvania PA COVID-19 Vaccine Task Force/PA Department of Health JANUARY 19, 2021 |VERSION 5.0 PENNSYLVANIA COVID-19 INTERIM VACCINATION PLAN Table of Contents Introduction……………………………………………………………………………………………………………………………………….2 Section 1: COVID-19 Vaccination Preparedness Planning ......................................................................... 3 Section 2: COVID-19 Organizational Structure and Partner Involvement ................................................. 4 Section 3: Phased Approach to COVID-19 Vaccination ........................................................................... 11 Section 4: Critical Populations ................................................................................................................. 17 Section 5: COVID-19 Provider Recruitment and Enrollment ................................................................... 21 Section 6: COVID-19 Vaccine Administration Capacity ........................................................................... 25 1. Health and Medical Infrastructure .......................................................................................... 25 2. Occupational Health Clinics and Closed Points of Dispensing (PODs) ..................................... 26 3. Expanded Outreach to Ensure Vaccine Access ........................................................................ 27 4. Staffing ....................................................................................................................................